April 2013 Editor's Picks: Products from Axiom Analytical and I Holland - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

April 2013 Editor's Picks: Products from Axiom Analytical and I Holland

Equipment and Processing Report

Featured products from Pharmaceutical Technology's monthly newsletter, Equipment & Processing Report

Axiom Analytical
Shielded and self-cleaning near-infrared probes are designed for on-line analysis

Axiom added shielded and self-cleaning near-infrared (NIR) probes to its line of robust probes designed for on-line spectroscopic analysis. The FPT-850SJ NIR transmission probe includes an integral steam jacket that facilitates the elimination of condensed sample material without requiring probe removal. The FDR-825 non-contact NIR diffuse-reflectance probe uses a vortex flushing system that allows the objective optics to be effectively cleaned while in place on the process line. The on-line probes have a robust seal around the viewing window that is resistant to extreme conditions of temperature, pressure, and chemical reactivity.


I Holland
Tablet-design software aids in design of tablet parameters and performs stress analysis for tool tips

I Holland’s iTAB tablet-design software calculates tablet parameters and performs stress analysis to help users design pharmaceutical tablets. The software first calculates tablet-design parameters (e.g., volume, mass, density, and surface area) as the user modifies tablet dimensions (e.g., diameter, cup depth, and radii). The software next runs a real-time, integrated finite element analysis (FEA) simulation against the design and calculates a punch-tip maximum force. Using this analysis in the design step helps eliminate problems such as punch-tip breakage. The software produces a two-dimensional drawing and generates a design report that can be emailed to I Holland for further analysis, design work, and tooling production.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
8%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
Source: Equipment and Processing Report,
Click here